HIV Type 1 Abrogates TAP-Mediated Transport of Antigenic Peptides Presented by MHC Class I

Downregulation of MHC class I expression following human immunodeficiency virus 1 (HIV-1) infection is thought to play an important role in viral escape from immune recognition by cytotoxic T-lymphocytes (CTLs). Since exogenous addition of HIV-1-derived peptides restores susceptibility of HIV-1-infected cells to CTL-mediated lysis, we tested whether endogenous peptide loading is impaired in these cells. Our results show that in HIV-1-infected cells the ability of the transporter associated with antigen presentation (TAP) to translocate antigenic peptides from the cytosol to the lumen of the ER for presentation on MHC class I molecules is abolished. These data suggest that interference with the supply of antigenic peptides to the MHC class I pathway provides an additional mechanism by which HIV-1 evades the CTL-mediated immune response.

[1]  M. Bevan,et al.  An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S , 1992, The Journal of experimental medicine.

[2]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[3]  J. Yewdell,et al.  The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules , 1997, The Journal of experimental medicine.

[4]  D. Andrews,et al.  Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. , 1996, The EMBO journal.

[5]  B. Walker,et al.  Distinct Trafficking Pathways Mediate Nef-Induced and Clathrin-Dependent Major Histocompatibility Complex Class I Down-Regulation , 2000, Journal of Virology.

[6]  J. Salamero,et al.  Homozygous human TAP peptide transporter mutation in HLA class I deficiency. , 1994, Science.

[7]  K. Collins,et al.  HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway. , 2001, Virology.

[8]  P. Cresswell,et al.  The nature of the MHC class I peptide loading complex , 1999, Immunological reviews.

[9]  P. Cresswell,et al.  Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I- restricted cell-mediated lysis , 1991, The Journal of experimental medicine.

[10]  E. Wecker,et al.  Downregulation of HLA class I antigens in HIV-1-infected cells. , 1989, AIDS research and human retroviruses.

[11]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[12]  Maria L. Wei,et al.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.

[13]  P. Lehner,et al.  The human cytomegalovirus gene product US6 inhibits ATP binding by TAP , 2001, The EMBO journal.

[14]  F. Lemonnier,et al.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.

[15]  B. Walker,et al.  Immunologic control of HIV-1. , 2002, Annual review of medicine.

[16]  M. Bevan,et al.  Defective presentation of endogenous antigen by a cell line expressing class I molecules. , 1990, Science.

[17]  J. Neefjes,et al.  Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.

[18]  J. Neefjes,et al.  Membrane topology and dimerization of the two subunits of the transporter associated with antigen processing reveal a three-domain structure. , 1999, Journal of immunology.

[19]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[20]  C. Kneitz,et al.  Mechanism of MHC class I downregulation in HIV infected cells. , 1992, Immunobiology.

[21]  H. Sjögren,et al.  Peptide-bound Major Histocompatibility Complex Class I Molecules Associate with Tapasin before Dissociation from Transporter Associated with Antigen Processing* , 1999, The Journal of Biological Chemistry.

[22]  R. Siliciano,et al.  The challenge of viral reservoirs in HIV-1 infection. , 2002, Annual review of medicine.

[23]  R. Phillips,et al.  Escape of human immunodeficiency virus from immune control. , 1997, Annual review of immunology.

[24]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[25]  J. Yewdell,et al.  Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.

[26]  J. Scheppler,et al.  Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. , 1989, Journal of immunology.

[27]  A. Townsend,et al.  Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter , 1991, Nature.

[28]  P. Cresswell,et al.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Desrosiers,et al.  Viral persistence: HIV's strategies of immune system evasion. , 2002, Annual review of medicine.

[30]  D. Singer,et al.  Repression of MHC class I gene promoter activity by two-exon Tat of HIV. , 1993, Science.

[31]  J. Neefjes,et al.  The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.

[32]  M. Androlewicz.  Peptide generation in the major histocompatibility complex class I antigen processing and presentation pathway , 2001, Current opinion in hematology.

[33]  S. Le Gall,et al.  Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. , 1998, Immunity.

[34]  E. Harhaj,et al.  Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides. , 1999, Journal of immunology.

[35]  M. Androlewicz.  The role of tapasin in MHC class I antigen assembly , 1999, Immunologic research.